UK HealthTech and life sciences startups raised 拢1.4bn in venture capital investment in Q1 2025, the sector鈥檚 second strongest quarter on record, according to new analysis from HSBC Innovation Banking UK and Dealroom.聽
Health was the UK鈥檚 most funded sector this quarter by a wide margin, attracting more than twice the investment of the next largest sector.聽
Nearly half of all VC investment in the sector went to AI-powered startups, highlighting the technology鈥檚 growing influence on healthcare innovation.
Overall, UK innovation businesses raised 拢3.2bn in Q1 2025, an 8% increase compared to the same period last year and the highest Q1 amount since 2022.
Most UK venture capital in Q1 was raised at breakout stage (Series B and C) with over 拢1.4 bn, closely followed by 拢1.3bn at late stage.
There is also evidence that UK startups are looking beyond equity to alternative sources of funding. Debt funding surged to 拢760m in Q1 2025, rebounding sharply from H2 2024 levels and signalling renewed lender confidence.
The UK leads Europe in several key areas, including VC investment, the number of unicorns, and overall enterprise value.
It has produced 185 unicorns, more than any other European country, including one new addition this year.
Simon Bumfrey, CEO, HSBC Innovation Banking UK said: 鈥淚t’s exciting to see UK HealthTech firms thriving and attracting near-record investment, driven by AI innovations transforming the sector and unlocking exciting new possibilities.聽
鈥淭his comes as VC investment in UK innovation businesses has risen year on year, with notable megarounds and increasing breakout-stage funding strengthening the pipeline.聽
鈥淭his is a testament to the resilience of the innovation ecosystem, which has weathered an uncertain operating environment to continue attracting investment.
鈥淭he UK remains Europe鈥檚 innovation powerhouse 鈥� driving revenue, producing more unicorns, and capturing a growing share of VC investment.聽
鈥淲ith rising early stage investment, fast-growing sectors, and standout IPO candidates, we鈥檙e excited to see what the rest of the year holds for the UK innovation economy and remain focused on supporting firms to accelerate growth across the ecosystem.鈥�